Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Sergio, Venturini"'
Autor:
Daniele Orso, Caterina Maria Fodale, Sara Fossati, Sergio Venturini, Federico Fonda, Francesco Cugini, Irene Comisso, Massimo Crapis, Luisa Cacciavillani, Tiziana Bove
Publikováno v:
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Patients undergoing Extracorporeal Membrane Oxygenation (ECMO) are particularly susceptible to infections: 42% experience sepsis and 26% develop a nosocomial infection (NI). Whether antibiotic prophylaxis is effective in reducing
Externí odkaz:
https://doaj.org/article/1852de0de00a4bbd9bfbb21b50ba1679
Autor:
Massimo Crapis, Sergio Venturini, Astrid Callegari, Giovanni Del Fabro, Igor Bramuzzo, Laura De Santi, Elisa Pontoni, Maurizio Tonizzo, Barbara Basso
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss Suppl. 2 (2024)
Introduction: Dalbavancin is a semisynthetic lipoglycopeptide long-acting antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Its features can be useful in the current healthcare scenario characteriz
Externí odkaz:
https://doaj.org/article/a1d8b680171246b58bb40c4e74923b3e
Autor:
Sergio Venturini, Raffaella Piccarreta
Publikováno v:
Journal of Statistical Software, Vol 100, Pp 1-35 (2021)
We introduce the new package dmbc that implements a Bayesian algorithm for clustering a set of binary dissimilarity matrices within a model-based framework. Specifically, we consider the case when S matrices are available, each describing the dissimi
Externí odkaz:
https://doaj.org/article/dda3ba796189475aa83490e5cbe7f0bc
Autor:
Daniele Generali, Giancarlo Bosio, Fabio Malberti, Antonio Cuzzoli, Sophie Testa, Laura Romanini, Antonio Fioravanti, Alessandro Morandini, Luca Pianta, Guglielmo Giannotti, Erika Maria Viola, Matteo Giorgi-Pierfranceschi, Marina Foramitti, Rosa Angela Tira, Ilaria Zangrandi, Giulia Chiodelli, Andrea Machiavelli, Maria Rosa Cappelletti, Alessia Giossi, Valeria De Giuli, Chiara Costanzi, Chiara Campana, Ottavia Bernocchi, Marianna Sirico, Alessia Zoncada, Alfredo Molteni, Sergio Venturini, Fabiola Giudici, Maurizio Scaltriti, Angelo Pan
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 433-440 (2021)
Objectives: Canakinumab is an IL-1β antibody that neutralises the activity of IL-1β. This study examined the efficacy and safety of canakinumab in patients with moderate COVID-19-related pneumonia. Design: This study aimed to evaluate the reduction
Externí odkaz:
https://doaj.org/article/43321c41d17e4354b37611a7055eca43
Autor:
Sergio Venturini, Mehmet Mehmetoglu
Publikováno v:
Journal of Statistical Software, Vol 88, Iss 1, Pp 1-35 (2019)
We provide a package called plssem that fits partial least squares structural equation models, which is often considered an alternative to the commonly known covariance-based structural equation modeling. plssem is developed in line with the algorith
Externí odkaz:
https://doaj.org/article/69c5be87ea6f4706ae5ddcdfb7c5d4f7
Autor:
Danilo Villalta, Paola Martelli, Anna Moratto, Valeria Salgarolo, Elita Ligato, Mariaelisabetta Conte, Roberto Giacomello, Tommaso Pellis, Rita De Rosa, Sergio Venturini, Massimo Crapis
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss , Pp e00227- (2021)
Background: Recently many serological assays for detection of antibodies to SARS-COV-2 virus were introduced on the market. Aim of this study was to assess the diagnostic performance of an automated CLIA for quantitative detection of anti-SARS-CoV-2
Externí odkaz:
https://doaj.org/article/5fd219ba1bcb449f8718351afe0f44df
Autor:
Ingrid Reffo, Manuela Avolio, Sergio Venturini, Giancarlo Basaglia, Massimo Crapis, Gabriella Nadalin
Publikováno v:
Médecine et Maladies Infectieuses Formation. 2:37-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::204a383084b1fc8c12b3a177ff39fa0a
https://doi.org/10.1016/j.mmifmc.2022.11.004
https://doi.org/10.1016/j.mmifmc.2022.11.004
Autor:
Rebecca Graziani, Sergio Venturini
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231876 (2020)
In this paper we suggest a new Bayesian approach to network meta-analysis for the case of discrete multiple outcomes. The joint distribution of the discrete outcomes is modeled through a Gaussian copula with binomial marginals. The remaining elements
Externí odkaz:
https://doaj.org/article/9525c86605f241d696562f3ab8e889ec
Publikováno v:
Pathogens, Vol 10, Iss 5, p 535 (2021)
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increase the risk of reactivation of latent tuberculosis (LTBI
Externí odkaz:
https://doaj.org/article/63fa4307227944e58542256095a49c89
Autor:
Francesco Schettini, Sergio Venturini, Mario Giuliano, Matteo Lambertini, David J. Pinato, Concetta Elisa Onesti, Pietro De Placido, Nadia Harbeck, Diana Lüftner, Hannelore Denys, Peter Van Dam, Grazia Arpino, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans Wildiers, Alessandra Gennari, Vivianne Tjan-Heijnen, Rupert Bartsch, Javier Cortes, Ida Paris, Miguel Martín, Sabino De Placido, Lucia Del Mastro, Guy Jerusalem, Giuseppe Curigliano, Aleix Prat, Daniele Generali
Publikováno v:
Scientia
CANCER TREATMENT REVIEWS
Cancer treatment reviews
CANCER TREATMENT REVIEWS
Cancer treatment reviews
Immunotherapy; PARP inhibitors; Pembrolizumab Immunoteràpia; Inhibidors de PARP; Pembrolizumab Inmunoterapia; Inhibidores de PARP; Pembrolizumab Metastatic triple-negative breast cancer (mTNBC) is a poor prognostic disease with limited treatments an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b4eda5fa74b8ce1e6191f822cb50ac
https://lirias.kuleuven.be/handle/20.500.12942/704477
https://lirias.kuleuven.be/handle/20.500.12942/704477
